Health product recall

MAR-Paliperidone Extended Release Tablets: Data Integrity

Last updated

Summary

Product
MAR-Paliperidone Extended Release tablets.
Issue
Health products » Product quality
What to do

See instructions below.

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot

MAR-Paliperidone

MAR-Paliperidone 3mg

DIN 02511010

Tablet (Extended-Release)

Paliperidone 3 mg

M210315

MAR-Paliperidone

MAR-Paliperidone 6mg

DIN 02511029

Tablet (Extended-Release)

Paliperidone 6mg

M210316

Issue

 Data integrity concerns with product's bioequivalence data.

What you should do

  1. Verify if your product is affected.
  2. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
  3. Contact the recalling firm if you have any questions about the recall.
  4. Report any health product related side effects to Health Canada.
  5. Report any other health product safety complaints to Health Canada.

Additional information

Background

Depth of Recall: Retailers 

Details
Original published date:
Alert / recall type
Health product recall
Category
Health product » Drugs
Companies

Marcan Pharmaceuticals Inc.

2 Gurdwara Road, Suite #112,

Ottawa, Ontario,

K2E 1A2

Published by
Health Canada
Audience
General public
Health professionals
Hospitals
Recall class
Type II
Identification number
RA-63596